Targeting the mTOR pathway using novel ATP‑competitive inhibitors, Torin1, Torin2 and XL388, in the treatment of glioblastoma
Author:
Affiliation:
1. Department of Neurosurgery, New York Medical College/Westchester Medical Center, Valhalla, NY 10595, USA
Publisher
Spandidos Publications
Subject
Cancer Research,Oncology
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. From signalling pathways to targeted therapies: unravelling glioblastoma’s secrets and harnessing two decades of progress;Signal Transduction and Targeted Therapy;2023-10-20
2. Sequential Treatment with Temozolomide Plus Naturally Derived AT101 as an Alternative Therapeutic Strategy: Insights into Chemoresistance Mechanisms of Surviving Glioblastoma Cells;International Journal of Molecular Sciences;2023-05-22
3. Defining the role of mTOR pathway in the regulation of stem cells of glioblastoma;Advances in Biological Regulation;2022-12
4. Upregulation of glutamate transporter 1 by mTOR/Akt pathway in astrocyte culture during oxygen–glucose deprivation and reoxygenation;Experimental Brain Research;2022-11-27
5. Research Progress on the Regulation Mechanism of Key Signal Pathways Affecting the Prognosis of Glioma;Frontiers in Molecular Neuroscience;2022-07-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3